Education
About Us
Working with TipRanks
Follow Us
Optimizerx Corporation (OPRX)
:OPRX
OPRX Analyst Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
OPRX Stock 12 Month Forecast
Average Price Target
$24.73
▲(49.79% Upside)
| Highest Price Target$32.00 | Average Price Target$24.73 | Lowest Price Target$15.65 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
$20→$16.5
Hold
-0.06%
Downside
Reiterated
11/08/25
AI Generated ArticleAI Generated Article
Roth MKM
$27→$32
Buy
93.82%
Upside
Assigned
11/07/25
Wall Street Analysts Are Bullish on Top Healthcare PicksWith net dollar revenue retention of 120% leaving 2025 revenue growth guidance of 18% looking conservative still, we reiterate our Buy rating. Our increased $32.00 price target ($27.00 prior) now applies a 5x revenue multiple (we used 4x prior) to our 2026 revenue forecast.
Lake Street
$24
Buy
45.37%
Upside
Reiterated
11/07/25
Stifel Nicolaus
$24.67→$15.65
Buy
-5.21%
Downside
Reiterated
11/07/25
William Blair
―
Buy
―
Reiterated
11/07/25
OptimizeRx: Strong Financial Performance and Promising Outlook Justify Buy RatingWe believe the solid performance and positive key performance indicators also point to underlying momentum in the business, providing incremental confidence in the setup for 2026. Looking forward, management continues to express confidence in the ability to embed more recurring-revenue, data services work with core DAAP customers, which we believe should provide incremental margin lift and improve revenue visibility over time (a key reason for the early look at 2026 guidance, in our view).The stock has been a year-to-date winner, with shares up nearly 265%, albeit off a trough valuation multiple. We believe the company is attractively positioned for continued share gains, producing durable organic revenue growth and strong operating leverage characteristics. We also applaud management’s aggressive use of cash to reduce high-interest debt.
B. Riley Securities
$18→$28
Buy
69.59%
Upside
Reiterated
11/07/25
Citizens JMP
$23→$24
Buy
45.37%
Upside
Reiterated
11/07/25
RBC Capital
$6
Hold
-63.66%
Downside
Downgraded
01/08/25
Stephens
$5.5
Hold
-66.69%
Downside
Initiated
12/19/24
Barclays
$5
Hold
-69.72%
Downside
Reiterated
11/14/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
$20→$16.5
Hold
-0.06%
Downside
Reiterated
11/08/25
AI Generated ArticleAI Generated Article
Roth MKM
$27→$32
Buy
93.82%
Upside
Assigned
11/07/25
Wall Street Analysts Are Bullish on Top Healthcare PicksWith net dollar revenue retention of 120% leaving 2025 revenue growth guidance of 18% looking conservative still, we reiterate our Buy rating. Our increased $32.00 price target ($27.00 prior) now applies a 5x revenue multiple (we used 4x prior) to our 2026 revenue forecast.
Lake Street
$24
Buy
45.37%
Upside
Reiterated
11/07/25
Stifel Nicolaus
$24.67→$15.65
Buy
-5.21%
Downside
Reiterated
11/07/25
William Blair
―
Buy
―
Reiterated
11/07/25
OptimizeRx: Strong Financial Performance and Promising Outlook Justify Buy RatingWe believe the solid performance and positive key performance indicators also point to underlying momentum in the business, providing incremental confidence in the setup for 2026. Looking forward, management continues to express confidence in the ability to embed more recurring-revenue, data services work with core DAAP customers, which we believe should provide incremental margin lift and improve revenue visibility over time (a key reason for the early look at 2026 guidance, in our view).The stock has been a year-to-date winner, with shares up nearly 265%, albeit off a trough valuation multiple. We believe the company is attractively positioned for continued share gains, producing durable organic revenue growth and strong operating leverage characteristics. We also applaud management’s aggressive use of cash to reduce high-interest debt.
B. Riley Securities
$18→$28
Buy
69.59%
Upside
Reiterated
11/07/25
Citizens JMP
$23→$24
Buy
45.37%
Upside
Reiterated
11/07/25
RBC Capital
$6
Hold
-63.66%
Downside
Downgraded
01/08/25
Stephens
$5.5
Hold
-66.69%
Downside
Initiated
12/19/24
Barclays
$5
Hold
-69.72%
Downside
Reiterated
11/14/24
Best Analysts Covering OptimizeRx
1 Month
xxx
Success Rate
12/18 ratings generated profit
Average Return
+7.89%
assigned a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +7.89% per trade.
3 Months
xxx
Success Rate
9/12 ratings generated profit
Average Return
+20.06%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +20.06% per trade.
1 Year
Success Rate
10/12 ratings generated profit
Average Return
+123.34%
reiterated a buy rating 6 days ago
Copying Constantine Davides's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +123.34% per trade.
2 Years
xxx
Success Rate
12/12 ratings generated profit
Average Return
+147.73%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +147.73% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
OPRX Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Oct 25
Nov 25
Strong Buy
2
2
1
1
5
Buy
12
10
9
7
10
Hold
1
2
7
7
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
14
17
15
23
Each month's total comprises the sum of three months' worth of ratings.
OPRX Financial Forecast
OPRX Stock Forecast FAQ
What is OPRX’s average 12-month price target, according to analysts?
Based on analyst ratings, Optimizerx Corporation’s 12-month average price target is 24.73.
What is OPRX’s upside potential, based on the analysts’ average price target?
Optimizerx Corporation has 49.79% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is OPRX a Buy, Sell or Hold?
Optimizerx Corporation has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
What is Optimizerx Corporation’s price target?
The average price target for Optimizerx Corporation is 24.73. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $32.00 ,the lowest forecast is $15.65. The average price target represents 49.79% Increase from the current price of $16.51.
The highest analyst price target is $32.00 ,the lowest forecast is $15.65. The average price target represents 49.79% Increase from the current price of $16.51.
What do analysts say about Optimizerx Corporation?
Optimizerx Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of OPRX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.